Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroblastoma 3Ganglioneuroblastoma 3Wilms Tumor 1Testicular Neoplasms 1Teratoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Ovarian Germ Cell Cancer 1Endodermal Sinus Tumor 1Carcinoma, Renal Cell 1

Interventions

Vincristine 7Doxorubicin 7Etoposide 6Dactinomycin 6Cyclophosphamide 6Radiotherapy 5Gene Expression Profiling 4Carboplatin 4X-Rays 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Polymerase Chain Reaction 3Filgrastim 3DNA Methylation 3Surgical Procedures, Operative 2Radiotherapy, Conformal 2Phantoms, Imaging 2Microarray Analysis 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Amplified Fragment Length Polymorphism Analysis 2lorvotuzumab mertansine 1liposomal amphotericin B 1Traumeel S 1Topotecan 1Thrombopoietin 1Spectrum Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Wilms Tumor × Congresses as Topic × Clear all
NCT00335556 2017-07-21

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Children's Oncology Group

Phase 2 Completed
291 enrolled 18 charts
Genitourinary

Carcinoma, Renal Cell, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡